Pfizer Inc
NYSE: PFE
$29.36
-$0.06 (-0.2%)
Real Time Data Delayed 15 Min.
PFE Articles
Last week, a few biotech companies made absolutely massive runs, and some had serious falls.
Published:
Last Updated:
October 30, 2015: Markets opened higher on Friday before falling into the red until the early afternoon. Financial stocks could not get untracked, but energy stocks were able to pick up the slack. It...
Published:
Last Updated:
ThinkstockOctober 29, 2015: Markets opened lower on Thursday after a GDP report that was a bit softer than expected and a somewhat better-than-expected report on new jobless claims. Quarterly results...
Published:
Last Updated:
Allergan has issued a press release that confirms some of the rumors floating in the market that it has been approached by Pfizer.
Published:
Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Published:
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
Most investors have had a rough 2015, and with the Nasdaq the only index that is up for the year as of Friday, the question is what's the game plan for the rest of the year?
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Published:
24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and found four outstanding companies.
Published:
ThinkstockOctober 21, 2015: Markets opened higher on Wednesday on the trail of gains in both Japan and Europe. Shanghai closed down and the dollar index was lower as well. Crude oil for December...
Published:
Last Updated:
ThinkstockOctober 20, 2015: Markets opened lower on again on Tuesday as investors trailed along after mixed Asian and European equities markets. In Europe prospects for further central bank easing...
Published:
Last Updated:
Tuesday's top analyst upgrades, downgrades and initiations include Bluebird Bio, Boston Beer, Etsy, Gilead Sciences, Pfizer, PMC-Sierra and Valeant Pharmaceuticals.
Published:
Last Updated:
ThinkstockOctober 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech stocks continue to get new life, helping overcome some softness in...
Published:
Last Updated:
The bottom line is volatility at higher levels may be here to stay for some time. Owning low-multiple, dividend-paying blue chip leaders makes good sense for long-term growth portfolios.
Published: